Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
- PMID: 35817223
- PMCID: PMC9265239
- DOI: 10.1016/j.jhep.2022.06.029
Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
Keywords: COVID-19; autoimmune; primary biliary cholangitis.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Figures

Comment on
-
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.J Hepatol. 2022 Sep;77(3):653-659. doi: 10.1016/j.jhep.2022.03.040. Epub 2022 Apr 21. J Hepatol. 2022. PMID: 35461912 Free PMC article.
References
-
- EASL Clinical Practice Guidelines The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–172. - PubMed
-
- Lindor K.D., Bowlus C.L., Boyer J., Levy C., Mayo M. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69:394–419. - PubMed
-
- Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938. - PubMed
-
- Chazouillères O., Wendum D., Serfaty L., Montembault S., Rosmorduc O., Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28:296–301. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous